{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:12:00Z","timestamp":1789744320203,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006090","name":"Global Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.coviro.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T12:20:21Z","timestamp":1586434821000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Tracking progress in universal influenza vaccine development"],"prefix":"10.1016","volume":"40","author":[{"given":"Julie","family":"Ostrowsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Arpey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Osterholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Friede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Molto-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Seals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-0797","authenticated-orcid":false,"given":"Joseph","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.02.003_bib0005","unstructured":"US Centers for Disease Control and Prevention: Past seasons vaccine effectiveness estimates. Adjusted vaccine effectiveness estimates for influenza seasons from 2004-2018. https:\/\/www.cdc.gov\/flu\/vaccines-work\/past-seasons-estimates.html."},{"key":"10.1016\/j.coviro.2020.02.003_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-018-0340-z","article-title":"Current and future influenza vaccines","volume":"25","author":"Yamayoshi","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2020.02.003_sbref0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a universal influenza virus vaccine possible?","volume":"71","author":"Nachbagauer","year":"2020","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coviro.2020.02.003_sbref0020","series-title":"Accelerating the Development of a Universal Influenza Vaccine","author":"Sabin-Aspen Vaccine Science Policy Group","year":"2019"},{"key":"10.1016\/j.coviro.2020.02.003_bib0025","series-title":"NIH forms new collaborative influenza vaccine research network","author":"National Institute of Allergy and Infectious Diseases","year":"2019"},{"key":"10.1016\/j.coviro.2020.02.003_bib0030","series-title":"Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development","author":"Bill and Melinda Gates Foundation","year":"2018"},{"key":"10.1016\/j.coviro.2020.02.003_bib0035","doi-asserted-by":"crossref","DOI":"10.3201\/eid2502.180359","article-title":"Public health-driven research and innovation for next-generation influenza vaccines, European Union","volume":"25","author":"Navarro-Torn\u00e9","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06228-8","article-title":"A naturally protective epitope of limited variability as an influenza vaccine target","volume":"9","author":"Thompson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.02.003_bib0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fimmu.2018.01479","article-title":"The hurdles from bench to bedside in the realization and implementation of a universal influenza vaccine","volume":"9","author":"Valkenburg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.02.003_sbref0055","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","article-title":"Universal influenza vaccines: shifting to better vaccines","volume":"34","author":"Berlanda Scorza","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.02.003_bib0060","series-title":"Global Influenza Strategy 2019-2030","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.coviro.2020.02.003_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vaccine.2018.11.037","article-title":"Global Funders Consortium for Universal Influenza Vaccine Development","volume":"37","author":"Bresee","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.02.003_bib0070","unstructured":"Center for Infectious Disease Research and Policy: Influenza Vaccines Roadmap. http:\/\/www.cidrap.umn.edu\/ongoing-programs\/influenza-vaccines-roadmap."},{"key":"10.1016\/j.coviro.2020.02.003_bib0075","series-title":"Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health","author":"The White House","year":"2019"},{"key":"10.1016\/j.coviro.2020.02.003_bib0080","series-title":"Global Vaccine Action Plan 2011-2020","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.coviro.2020.02.003_bib0085","series-title":"WHO Preferred Product Characteristics for Next Generation Influenza Vaccines","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.coviro.2020.02.003_bib0090","unstructured":"World Health Organization: Vaccine Pipeline Tracker. http:\/\/www.who.int\/immunization\/research\/vaccine_pipeline_tracker_spreadsheet\/en\/."},{"key":"10.1016\/j.coviro.2020.02.003_bib0095","unstructured":"PATH: RSV Vaccine and mAb Trial Tracker. https:\/\/vaccineresources.org\/details.php?i=2682."},{"key":"10.1016\/j.coviro.2020.02.003_bib0100","unstructured":"International AIDS Vaccine Initiative: Database of Preventative HIV Vaccine Candidates. https:\/\/www.iavi.org\/trials-database\/."},{"key":"10.1016\/j.coviro.2020.02.003_bib0105","unstructured":"Center for Infectious Disease Research and Policy, University of Minnesota: Universal Influenza Vaccine Technology Landscape. http:\/\/www.cidrap.umn.edu\/universal-influenza-vaccine-technology-landscape."},{"key":"10.1016\/j.coviro.2020.02.003_bib0110","unstructured":"US National Institutes of Health, National Library of Medicine: ClinicalTrials.govhttps:\/\/clinicaltrials.gov\/."},{"key":"10.1016\/j.coviro.2020.02.003_bib0115","unstructured":"World Health Organization: International Clinical Trials Registry Platform (ICTRP). http:\/\/www.who.int\/ictrp\/en\/."},{"key":"10.1016\/j.coviro.2020.02.003_bib0120","series-title":"EU Clinical Trials Register","author":"European Medicines Agency","year":"2019"},{"key":"10.1016\/j.coviro.2020.02.003_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coi.2018.04.001","article-title":"Development of next generation hemagglutinin-based broadly protective influenza virus vaccines","volume":"53","author":"Nachbagauer","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2020.02.003_bib0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture","volume":"9","author":"Raj\u00e3o","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.02.003_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines6020029","article-title":"Clinical advances in viral-vectored influenza vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2020.02.003_bib0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fimmu.2018.00600","article-title":"Novel platforms for the development of a universal influenza vaccine","volume":"9","author":"Kumar","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.02.003_bib0145","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14760584.2018.1541408","article-title":"Universal influenza vaccines: from viruses to nanoparticles","volume":"17","author":"Wang","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2020.02.003_bib0150","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acsinfecdis.8b00206","article-title":"A perspective on nanoparticle universal influenza vaccines","volume":"4","author":"Deng","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0155","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fimmu.2018.01568","article-title":"A review of DNA vaccines against influenza","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.02.003_bib0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/vaccines6020020","article-title":"New kids on the block: RNA-based influenza virus vaccines","volume":"6","author":"Berlanda Scorza","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2020.02.003_sbref0165","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/jiy696","article-title":"Immunodominance and antigenic variation of influenza virus hemagglutinin: Implications for design of universal vaccine immunogens","volume":"219","author":"Zost","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14712598.2019.1604671","article-title":"Universal influenza virus vaccines: what needs to happen next?","volume":"19","author":"Trucchi","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.coviro.2020.02.003_bib0175","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0180","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jiz004","article-title":"Universal influenza vaccine approaches employing full-length or head-only HA proteins","volume":"219","author":"Ross","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: Different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2020.02.003_bib0190","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiz003","article-title":"The role of M2e in the development of universal influenza vaccines","volume":"219","author":"Saelens","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.02.003_bib0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2018.03.024","article-title":"Vaccine options for influenza: thinking small","volume":"53","author":"Schepens","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2020.02.003_sbref0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/vaccines6020018","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2020.02.003_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2018.11.005","article-title":"Broadly protective influenza vaccines: design and production platforms","volume":"34","author":"Elbahesh","year":"2019","journal-title":"Curr Opin Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:01:01Z","timestamp":1761818461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"alternative-id":["S1879625720300043"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.02.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracking progress in universal influenza vaccine development","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}